Business Context and Reporting Period
Company: Lifevantage Corp (LifeVantage)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2008
Business Overview: LifeVantage primarily sells Protandim, a dietary supplement designed to increase antioxidant enzyme production. The company also sells an Omega 3 fish oil product, though sales have been negligible. Operations rely heavily on outsourced manufacturing and fulfillment. The company is classified as a smaller reporting company.
Key Financial Metrics
| Metric | Q3 2008 | Q3 2007 |
|---|---|---|
| Net Sales | $1,273,502 | $807,324 |
| Gross Profit | $1,037,963 | $630,021 |
| Gross Margin | 82% | 78% |
| Operating Expenses | $1,091,536 | $929,257 |
| Operating Loss | $(53,573) | $(299,236) |
| Net Loss | $(131,135) | $(298,704) |
| Cash and Cash Equivalents | $155,493 | $1,142,857 (End of Q3 2007) |
| Working Capital | $895,253 | $817,081 (June 30, 2008) |
| Revolving Line of Credit | $321,397 | $166,620 (June 30, 2008) |
| Convertible Debt | $260,035 | $223,484 (June 30, 2008) |
Material Changes vs. Prior Period
- Revenue Recognition Shift: Net sales increased 58% year-over-year, primarily driven by the recognition of approximately $511,000 in previously deferred revenue from retail distributors (GNC and Vitamin Cottage). Excluding this one-time recognition, organic sales were approximately $763,000.
- Operating Expenses: Total operating expenses increased by $162,000 (17%). Marketing and customer service expenses rose significantly ($210,000 increase) due to advertising and website redevelopment. Conversely, Research and Development expenses decreased by $138,000 due to reduced accrued expenses.
- Net Loss Improvement: The net loss narrowed to $(131,135) from $(298,704) in the prior year, largely attributable to the deferred revenue recognition. Without this adjustment, the net loss would have been approximately $(570,000).
- Cash Flow: Operating cash flow turned negative, using $243,640, compared to a positive $43,551 in the prior year. This was offset by $154,146 in financing cash flows from a revolving line of credit.
Guidance, Outlook, and Risks
- Outlook: Management believes current liquidity is sufficient to operate through at least June 30, 2009. The company is entering the network marketing sales channel via independent distributorships to boost sales.
- Liquidity Risks: The company holds $1,050,000 in Auction Rate Preferred Securities (ARPS). While classified as current assets, these have been adversely affected by the national liquidity crisis. Management expects redemption within 12 months but notes future economic events could impact classification.
- Debt Obligations: Convertible debentures issued in late 2007 bear 8% interest and are convertible at $0.20 per share. They contain redemption triggers (150% of principal) if the company fails to meet reporting requirements or undergoes a change of control.
- Operational Risks: The company faces risks related to limited operating history, dependence on third-party manufacturers, concentration of credit risk (GNC comprises 49% of accounts receivable), and the ability to generate sufficient cash from operations.
Investor Verification Checklist
- Deferred Revenue Impact: Verify the sustainability of revenue growth excluding the $511,000 one-time recognition of prior deferred sales.
- ARPS Liquidity: Confirm the status and redemption timeline of the $1,050,000 investment in Auction Rate Preferred Securities given market volatility.
- Debt Covenants: Review the terms of the convertible debentures regarding the 150% redemption penalty and the company's compliance with SEC reporting requirements.
- Customer Concentration: Assess the risk associated with GNC representing nearly half of the accounts receivable balance.
- Cash Burn Rate: Monitor the negative operating cash flow of $(243,640) against the stated runway to June 2009.